Document is current
Any future updates will be listed below
-
Authors
Fortress, Ashley M.
Miyagishima, Kiyoharu J.
Reed, Amberlynn A.
Temple, Sally
Clegg, Dennis O.
Tucker, Budd A.
Blenkinsop, Timothy A.
Harb, George
Greenwell, Thomas N.
Ludwig, Tenneille E.
Bharti, Kapil https://orcid.org/0000-0003-4884-3173
-
Funding
Funding for this research was provided by:
Division of Intramural Research, National Eye Institute
- License Information
-
More Information
Article History
Received: 9 November 2022
Accepted: 13 March 2023
First Online: 29 March 2023
Declarations
:
: Not applicable.
: Not applicable.
: ST is President of StemCultures; co-founder LUXA Biotech, Scientific Advisor: SANA Biotech; Vita Therapeutics; BlueRock Therapeutics. DOC is co-founder Regenerative Patch Technologies. GH is Vice President Regenerative Biology at Cellino. TEL is Director of WiCell Research Institute.
